Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Sio Gene Therapies coverage transferred at Chardan » 16:38
07/09/21
07/09
16:38
07/09/21
16:38
SIOX

Sio Gene Therapies

$2.50 /

+0.095 (+3.95%)

Chardan transferred…

Chardan transferred coverage of Sio Gene Therapies to analyst Geulah Livshits, who maintained a Buy rating and $12.50 price target on the stock.

ShowHide Related Items >><<
SIOX Sio Gene Therapies
$2.50 /

+0.095 (+3.95%)

SIOX Sio Gene Therapies
$2.50 /

+0.095 (+3.95%)

06/14/21 BTIG
Sio Gene Therapies initiated with a Buy at BTIG
04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
SIOX Sio Gene Therapies
$2.50 /

+0.095 (+3.95%)

Over a month ago
Initiation
Sio Gene Therapies initiated with a Buy at BTIG » 16:38
06/14/21
06/14
16:38
06/14/21
16:38
SIOX

Sio Gene Therapies

$2.52 /

+0.025 (+1.00%)

BTIG analyst Yun Zhong…

BTIG analyst Yun Zhong initiated coverage of Sio Gene Therapies with a Buy rating and $8 price target. The analyst believes the three clinical stage gene therapy programs that Sio licensed from partners let the company jumpstart the transformation process, and the progress that the company has since achieved in each program should support the company's continued growth into a "strong" gene therapy pure play.

ShowHide Related Items >><<
SIOX Sio Gene Therapies
$2.52 /

+0.025 (+1.00%)

SIOX Sio Gene Therapies
$2.52 /

+0.025 (+1.00%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
SIOX Sio Gene Therapies
$2.52 /

+0.025 (+1.00%)

SIOX Sio Gene Therapies
$2.52 /

+0.025 (+1.00%)

SIOX Sio Gene Therapies
$2.52 /

+0.025 (+1.00%)

Hot Stocks
Sio Gene Therapies provides information on upcoming milestones » 07:08
06/09/21
06/09
07:08
06/09/21
07:08
SIOX

Sio Gene Therapies

$2.29 /

+0.1 (+4.57%)

Siox Gene Therapies…

Siox Gene Therapies provided information on upcoming milestones. AXO-AAV-GM1 gene therapy for GM1 gangliosidosis: 12-month topline safety, biomarker, and efficacy data from the low-dose cohort in the second half of 2021; 12-month topline data from the first two patients dosed in the high-dose cohort in Q1 2022; meeting with the U.S. Food and Drug Administration to discuss the registrational pathway for AXO-AAV-GM1 in the first half of 2022. AXO-AAV-GM2 gene therapy for Tay-Sachs and Sandhoff disease: continued patient identification, screening, and enrollment in the ongoing dose-escalation study expected throughout FY2021. AXO-Lenti-PD gene therapy for Parkinson's disease: continued development of a scaled-up suspension-based manufacturing process at Oxford Biomedica to enable production of clinical trial material, with certification of at least one batch of clinical trial material by a Qualified Person expected in Q4 2021, following the successful manufacturing of both drug substance and drug product.

ShowHide Related Items >><<
SIOX Sio Gene Therapies
$2.29 /

+0.1 (+4.57%)

SIOX Sio Gene Therapies
$2.29 /

+0.1 (+4.57%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
SIOX Sio Gene Therapies
$2.29 /

+0.1 (+4.57%)

SIOX Sio Gene Therapies
$2.29 /

+0.1 (+4.57%)

SIOX Sio Gene Therapies
$2.29 /

+0.1 (+4.57%)

Hot Stocks
Sio Gene Therapies expects cash to sustain operations into 4Q22 » 07:05
06/09/21
06/09
07:05
06/09/21
07:05
SIOX

Sio Gene Therapies

$2.29 /

+0.1 (+4.57%)

"As of March 31,…

"As of March 31, 2021, we had $119M of cash and cash equivalents. We hold no short-term or long-term debt on the balance sheet. We estimate that our current cash and cash equivalents will sustain our operations into Q4 2022, beyond the expected dates of major upcoming milestones for our AXO-AAV-GM1 gene therapy program for the treatment of GM1 gangliosidosis," the company said.

ShowHide Related Items >><<
SIOX Sio Gene Therapies
$2.29 /

+0.1 (+4.57%)

SIOX Sio Gene Therapies
$2.29 /

+0.1 (+4.57%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
SIOX Sio Gene Therapies
$2.29 /

+0.1 (+4.57%)

SIOX Sio Gene Therapies
$2.29 /

+0.1 (+4.57%)

SIOX Sio Gene Therapies
$2.29 /

+0.1 (+4.57%)

Earnings
Sio Gene Therapies reports Q4 EPS (5c), consensus (17c) » 07:04
06/09/21
06/09
07:04
06/09/21
07:04
SIOX

Sio Gene Therapies

$2.29 /

+0.1 (+4.57%)

Pavan Cheruvu, CEO of Sio…

Pavan Cheruvu, CEO of Sio Gene Therapies said, "The positive data recently shared from our Phase 1/2 study of AXO-AAV-GM1, together with our industry-leading position in clinical enrollment and investment in earlier diagnosis, give us renewed momentum as we aim to advance this investigational therapy towards commercialization. In the second half of 2021, we will present 12-month follow-up data on safety, biomarkers, and clinical efficacy from the low-dose cohort of the GM1 gangliosidosis program. We expect these data, as well as a planned regulatory meeting with the FDA expected in the first half of 2022, will help define our registrational pathway in GM1 gangliosidosis. We have confidence in AXO-AAV-GM1 as well as our two other clinical-stage candidates in Tay-Sachs/Sandhoff disease and Parkinson's disease, and look forward to several major milestones across our three programs during this fiscal year. In parallel, we are continuing to build our preclinical and analytical development capabilities in our growing laboratory in Research Triangle Park, and are conducting a search and evaluation process for promising genetic medicines that may expand our pipeline with new product candidates in the years ahead. Our strengthened balance sheet leaves us well-positioned to develop first-in-class and best-in-class gene therapy product candidates in our current pipeline, while also investing in exciting new, biology-driven opportunities in areas of significant unmet patient need."

ShowHide Related Items >><<
SIOX Sio Gene Therapies
$2.29 /

+0.1 (+4.57%)

SIOX Sio Gene Therapies
$2.29 /

+0.1 (+4.57%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
SIOX Sio Gene Therapies
$2.29 /

+0.1 (+4.57%)

SIOX Sio Gene Therapies
$2.29 /

+0.1 (+4.57%)

SIOX Sio Gene Therapies
$2.29 /

+0.1 (+4.57%)

Conference/Events
UBS to hold a virtual conference » 04:55
05/26/21
05/26
04:55
05/26/21
04:55
NBTX

Nanobiotix

$16.16 /

+ (+0.00%)

, MRNA

Moderna

$169.25 /

+5.16 (+3.14%)

, TELA

Tela Bio

$13.85 /

+0.6 (+4.53%)

, ICLR

Icon

$229.34 /

-2.74 (-1.18%)

, AMWL

Amwell

$11.89 /

+0.38 (+3.30%)

, BRKR

Bruker

$69.86 /

+0.12 (+0.17%)

, SIOX

Sio Gene Therapies

$2.22 /

+0.01 (+0.45%)

, BMRN

BioMarin

$77.60 /

+0.08 (+0.10%)

, NVS

Novartis

$88.51 /

+0.51 (+0.58%)

, TERN

Terns Pharmaceuticals

$15.39 /

-0.62 (-3.87%)

, EAR

Eargo

$32.10 /

-1.12 (-3.37%)

, JAZZ

Jazz Pharmaceuticals

$177.71 /

-1.17 (-0.65%)

, TNDM

TNDM

/

+

, BAYRY

Bayer

$16.93 /

-0.265 (-1.54%)

, ANIK

Anika Therapeutics

$43.66 /

-0.55 (-1.24%)

, CVAC

CureVac

$115.64 /

+1.27 (+1.11%)

, BSX

Boston Scientific

$43.03 /

+0.215 (+0.50%)

, APLT

Applied Therapeutics

$18.57 /

+1.06 (+6.05%)

, ARVN

Arvinas

$65.15 /

-0.78 (-1.18%)

, PACB

Pacific Biosciences

$25.68 /

-0.1 (-0.39%)

, ABBV

AbbVie

$114.56 /

-1.35 (-1.16%)

, ZYXI

Zynex

$14.12 /

-0.61 (-4.14%)

, BAX

Baxter

$82.34 /

-0.42 (-0.51%)

, KOD

Kodiak Sciences

$82.62 /

+1.66 (+2.05%)

, ARWR

Arrowhead

$73.96 /

-0.83 (-1.11%)

, CUTR

Cutera

$36.98 /

-1.15 (-3.02%)

, TVTY

Tivity Health

$25.73 /

-0.09 (-0.35%)

, PTCT

PTC Therapeutics

$39.66 /

+0.52 (+1.33%)

, CTLT

Catalent

$103.45 /

+0.88 (+0.86%)

, RHHBY

Roche

$43.57 /

+ (+0.00%)

, CLPT

ClearPoint Neuro

$18.07 /

-0.38 (-2.06%)

, BNTX

BioNTech

$197.53 /

+2.64 (+1.35%)

, ALGN

Align Technology

$594.91 /

-9.47 (-1.57%)

, DBTX

Decibel Therapeutics

$7.85 /

-0.205 (-2.55%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference 2021 to be held on May 24-26.Webcast Link

ShowHide Related Items >><<
ZYXI Zynex
$14.12 /

-0.61 (-4.14%)

TVTY Tivity Health
$25.73 /

-0.09 (-0.35%)

TNDM TNDM
/

+

TERN Terns Pharmaceuticals
$15.39 /

-0.62 (-3.87%)

TELA Tela Bio
$13.85 /

+0.6 (+4.53%)

SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

RHHBY Roche
$43.57 /

+ (+0.00%)

PTCT PTC Therapeutics
$39.66 /

+0.52 (+1.33%)

PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

NVS Novartis
$88.51 /

+0.51 (+0.58%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

KOD Kodiak Sciences
$82.62 /

+1.66 (+2.05%)

JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

ICLR Icon
$229.34 /

-2.74 (-1.18%)

DBTX Decibel Therapeutics
$7.85 /

-0.205 (-2.55%)

CVAC CureVac
$115.64 /

+1.27 (+1.11%)

CUTR Cutera
$36.98 /

-1.15 (-3.02%)

CTLT Catalent
$103.45 /

+0.88 (+0.86%)

CLPT ClearPoint Neuro
$18.07 /

-0.38 (-2.06%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BRKR Bruker
$69.86 /

+0.12 (+0.17%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

BAX Baxter
$82.34 /

-0.42 (-0.51%)

ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

ARVN Arvinas
$65.15 /

-0.78 (-1.18%)

APLT Applied Therapeutics
$18.57 /

+1.06 (+6.05%)

AMWL Amwell
$11.89 /

+0.38 (+3.30%)

ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
MRNA Moderna
$169.25 /

+5.16 (+3.14%)

05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
05/07/21 Goldman Sachs
Moderna price target raised to $228 from $206 at Goldman Sachs
05/06/21 Piper Sandler
Moderna price target lowered to $231 from $234 at Piper Sandler
TELA Tela Bio
$13.85 /

+0.6 (+4.53%)

04/12/21 Piper Sandler
Reviews of Tela Bio's OviTex from two KOLs were positive, says Piper Sandler
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
03/25/21 Canaccord
Tela Bio pieces in place for accelerating growth, says Canaccord
01/14/21 Piper Sandler
Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss
ICLR Icon
$229.34 /

-2.74 (-1.18%)

05/10/21 Truist
PRA Health downgraded to Hold from Buy at Truist
05/03/21 Mizuho
Icon price target raised to $242 from $217 at Mizuho
04/29/21 Credit Suisse
Icon price target raised to $245 from $240 at Credit Suisse
04/20/21 Baird
PRA Health downgraded to Neutral from Outperform at Baird
AMWL Amwell
$11.89 /

+0.38 (+3.30%)

05/17/21 Guggenheim
Amwell upgraded to Buy from Neutral at Guggenheim
05/13/21 Piper Sandler
Amwell price target lowered to $20 from $30 at Piper Sandler
05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
BRKR Bruker
$69.86 /

+0.12 (+0.17%)

05/06/21 BTIG
Bruker price target raised to $80 from $73 at BTIG
05/06/21 SVB Leerink
Bruker price target raised to $80 from $70 at SVB Leerink
02/17/21 Stifel
Bruker price target raised to $65 from $48 at Stifel
02/17/21 Citi
Bruker price target raised to $65 from $57 at Citi
SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

04/30/21 Wedbush
BioMarin's Q1 revenue was better than expected, says Wedbush
04/26/21 Credit Suisse
BioMarin assumed with an Outperform at Credit Suisse
03/04/21 Guggenheim
BioMarin assumed at Buy from Neutral at Guggenheim
03/01/21 Evercore ISI
BioMarin upgraded to Outperform from In Line at Evercore ISI
NVS Novartis
$88.51 /

+0.51 (+0.58%)

05/11/21 Morgan Stanley
Novartis price target lowered to CHF 99 from CHF 102 at Morgan Stanley
04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
TERN Terns Pharmaceuticals
$15.39 /

-0.62 (-3.87%)

03/02/21 Cowen
Terns initiated with Outperform on NASH potential at Cowen
03/02/21 JPMorgan
Terns Pharmaceuticals initiated with an Overweight at JPMorgan
03/02/21 Cowen
Terns Pharmaceuticals initiated with an Outperform at Cowen
03/02/21 Goldman Sachs
Terns Pharmaceuticals initiated with a Buy at Goldman Sachs
EAR Eargo
$32.10 /

-1.12 (-3.37%)

05/13/21 Wells Fargo
Eargo price target lowered to $52 from $68 at Wells Fargo
05/12/21 JPMorgan
JPMorgan sees four 'compelling' MedTech opportunities after selloff
01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
TNDM TNDM
/

+

05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Tandem Diabetes initiated with an Underweight at Barclays
05/06/21 SVB Leerink
Tandem Diabetes price target raised to $102 from $95 at SVB Leerink
05/06/21 Oppenheimer
Tandem Diabetes price target raised to $135 from $130 at Oppenheimer
BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

05/19/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
05/19/21 JPMorgan
JPMorgan upgrades Bayer to Overweight with earnings at 'turning point'
05/18/21 JPMorgan
Bayer upgraded to Overweight from Neutral at JPMorgan
05/14/21 Berenberg
Bayer price target raised to EUR 74 from EUR 68 at Berenberg
ANIK Anika Therapeutics
$43.66 /

-0.55 (-1.24%)

12/16/20 Barrington
Anika Therapeutics upgraded to Outperform with $43 target at Barrington
12/16/20 Barrington
Anika Therapeutics upgraded to Outperform from Market Perform at Barrington
CVAC CureVac
$115.64 /

+1.27 (+1.11%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

05/24/21 Barclays
Boston Scientific initiated with an Overweight at Barclays
05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
04/29/21 Truist
Boston Scientific price target raised to $50 from $42 at Truist
APLT Applied Therapeutics
$18.57 /

+1.06 (+6.05%)

11/17/20 Barclays
Applied Therapeutics price target lowered to $44 from $64 at Barclays
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
ARVN Arvinas
$65.15 /

-0.78 (-1.18%)

05/20/21 UBS
Arvinas initiated with a Buy at UBS
04/21/21 Truist
Truist starts Arvinas with a Buy on PROTACs potential
04/21/21 Truist
Arvinas initiated with a Buy at Truist
03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

05/19/21 Piper Sandler
Piper 'incrementally bullish' on Biohaven, AbbVie migraine drugs
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
ZYXI Zynex
$14.12 /

-0.61 (-4.14%)

04/29/21 Piper Sandler
Zynex price target lowered to $15 from $19 at Piper Sandler
03/09/21 Northland
Zynex upgraded to Outperform from Market Perform at Northland
02/26/21 B. Riley
B. Riley downgrades Zynex to Neutral on 'deteriorating profitability'
02/26/21 B. Riley
Zynex downgraded to Neutral from Buy at B. Riley Securities
BAX Baxter
$82.34 /

-0.42 (-0.51%)

05/24/21 Barclays
Baxter initiated with an Equal Weight at Barclays
04/30/21 Citi
Baxter price target raised to $98 from $94 at Citi
04/29/21 Piper Sandler
Baxter price target raised to $85 from $80 at Piper Sandler
KOD Kodiak Sciences
$82.62 /

+1.66 (+2.05%)

05/11/21 Roth Capital
Roth Capital upgrades Kodiak Sciences to Buy on recent selloff
05/11/21 Roth Capital
Kodiak Sciences upgraded to Buy from Neutral at Roth Capital
05/11/21 BMO Capital
Kodiak Sciences price target lowered to $104 from $138 at BMO Capital
05/11/21 Barclays
Kodiak Sciences price target lowered to $86 from $90 at Barclays
ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

02/08/21 B. Riley
Arrowhead price target raised to $106 from $98 at B. Riley Securities
02/08/21 Citi
Arrowhead price target raised to $110 from $90 at Citi
02/05/21 Chardan
Arrowhead price target raised to $97 from $81 at Chardan
02/05/21 H.C. Wainwright
Arrowhead price target raised to $95 from $90 at H.C. Wainwright
CUTR Cutera
$36.98 /

-1.15 (-3.02%)

03/05/21 Piper Sandler
Cutera price target raised to $42 from $38 at Piper Sandler
02/18/21 Piper Sandler
Cutera price target raised to $38 from $28 at Piper Sandler
11/05/20 Piper Sandler
Cutera price target raised to $28 from $22 at Piper Sandler
09/14/20 Stephens
Cutera price target raised to $24 from $18 at Stephens
TVTY Tivity Health
$25.73 /

-0.09 (-0.35%)

02/25/21 Barrington
Tivity Health price target raised to $32 from $28 at Barrington
02/25/21 Piper Sandler
Tivity Health price target raised to $27 from $16 at Piper Sandler
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform with $19 target at Credit Suisse
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform from Neutral at Credit Suisse
PTCT PTC Therapeutics
$39.66 /

+0.52 (+1.33%)

05/17/21 Truist
PTC Therapeutics price target lowered to $65 from $75 at Truist
04/26/21 Credit Suisse
PTC Therapeutics assumed with a Neutral at Credit Suisse
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
CTLT Catalent
$103.45 /

+0.88 (+0.86%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
RHHBY Roche
$43.57 /

+ (+0.00%)

05/05/21 BTIG
Mereo BioPharma initiated with a Buy at BTIG
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
CLPT ClearPoint Neuro
$18.07 /

-0.38 (-2.06%)

03/18/21 Lake Street
Lake Street starts ClearPoint Neuro at Buy, sees 'billion-dollar' cap potential
03/18/21 Lake Street
ClearPoint Neuro initiated with a Buy at Lake Street
02/22/21 B. Riley
ClearPoint Neuro price target raised to $38 from $23 at B. Riley Securities
01/22/21 B. Riley
ClearPoint Neuro price target raised to $23 from $18 at B. Riley Securities
BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
05/11/21
Fly Intel: Top five analyst downgrades
ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

04/29/21 SVB Leerink
Align Technology price target raised to $770 from $690 at SVB Leerink
04/29/21 Credit Suisse
Align Technology price target raised to $715 from $693 at Credit Suisse
04/29/21 Stifel
Align Technology price target raised to $750 from $650 at Stifel
04/29/21 Baird
Align Technology price target raised to $745 from $655 at Baird
DBTX Decibel Therapeutics
$7.85 /

-0.205 (-2.55%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
ZYXI Zynex
$14.12 /

-0.61 (-4.14%)

TVTY Tivity Health
$25.73 /

-0.09 (-0.35%)

TNDM TNDM
/

+

TELA Tela Bio
$13.85 /

+0.6 (+4.53%)

SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

RHHBY Roche
$43.57 /

+ (+0.00%)

PTCT PTC Therapeutics
$39.66 /

+0.52 (+1.33%)

PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

NVS Novartis
$88.51 /

+0.51 (+0.58%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

KOD Kodiak Sciences
$82.62 /

+1.66 (+2.05%)

JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

ICLR Icon
$229.34 /

-2.74 (-1.18%)

EAR Eargo
$32.10 /

-1.12 (-3.37%)

CUTR Cutera
$36.98 /

-1.15 (-3.02%)

CTLT Catalent
$103.45 /

+0.88 (+0.86%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BRKR Bruker
$69.86 /

+0.12 (+0.17%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

BAX Baxter
$82.34 /

-0.42 (-0.51%)

ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

ARVN Arvinas
$65.15 /

-0.78 (-1.18%)

APLT Applied Therapeutics
$18.57 /

+1.06 (+6.05%)

AMWL Amwell
$11.89 /

+0.38 (+3.30%)

ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

  • 19
    Feb
  • 12
    Feb
  • 12
    Feb
  • 05
    Feb
  • 28
    Jan
  • 15
    Jan
  • 16
    Dec
  • 11
    Dec
  • 23
    Nov
  • 18
    Nov
  • 11
    Nov
  • 21
    Oct
  • 16
    Oct
  • 17
    Sep
  • 12
    Aug
  • 14
    Aug
  • 23
    Jul
  • 15
    Jul
  • 26
    Jun
  • 11
    Jun
RHHBY Roche
$43.57 /

+ (+0.00%)

PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

NVS Novartis
$88.51 /

+0.51 (+0.58%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

ICLR Icon
$229.34 /

-2.74 (-1.18%)

CVAC CureVac
$115.64 /

+1.27 (+1.11%)

CTLT Catalent
$103.45 /

+0.88 (+0.86%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

BAX Baxter
$82.34 /

-0.42 (-0.51%)

ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

TERN Terns Pharmaceuticals
$15.39 /

-0.62 (-3.87%)

SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

RHHBY Roche
$43.57 /

+ (+0.00%)

PTCT PTC Therapeutics
$39.66 /

+0.52 (+1.33%)

NVS Novartis
$88.51 /

+0.51 (+0.58%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

ICLR Icon
$229.34 /

-2.74 (-1.18%)

DBTX Decibel Therapeutics
$7.85 /

-0.205 (-2.55%)

CVAC CureVac
$115.64 /

+1.27 (+1.11%)

CTLT Catalent
$103.45 /

+0.88 (+0.86%)

CLPT ClearPoint Neuro
$18.07 /

-0.38 (-2.06%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BRKR Bruker
$69.86 /

+0.12 (+0.17%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

BAX Baxter
$82.34 /

-0.42 (-0.51%)

ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

ARVN Arvinas
$65.15 /

-0.78 (-1.18%)

APLT Applied Therapeutics
$18.57 /

+1.06 (+6.05%)

AMWL Amwell
$11.89 /

+0.38 (+3.30%)

ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

ZYXI Zynex
$14.12 /

-0.61 (-4.14%)

SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

EAR Eargo
$32.10 /

-1.12 (-3.37%)

CVAC CureVac
$115.64 /

+1.27 (+1.11%)

CLPT ClearPoint Neuro
$18.07 /

-0.38 (-2.06%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

AMWL Amwell
$11.89 /

+0.38 (+3.30%)

ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

Conference/Events
UBS to hold a virtual conference » 04:55
05/25/21
05/25
04:55
05/25/21
04:55
NBTX

Nanobiotix

$16.16 /

+ (+0.00%)

, MRNA

Moderna

$164.12 /

+2.565 (+1.59%)

, TELA

Tela Bio

$13.25 /

-0.05 (-0.38%)

, ICLR

Icon

$232.11 /

+1.2 (+0.52%)

, AMWL

Amwell

$11.54 /

-0.16 (-1.37%)

, BRKR

Bruker

$69.74 /

+0.64 (+0.93%)

, SIOX

Sio Gene Therapies

$2.22 /

+0.015 (+0.68%)

, BMRN

BioMarin

$77.49 /

-0.63 (-0.81%)

, NVS

Novartis

$88.00 /

-0.065 (-0.07%)

, TERN

Terns Pharmaceuticals

$15.80 /

-0.11 (-0.69%)

, EAR

Eargo

$33.22 /

+1.17 (+3.65%)

, JAZZ

Jazz Pharmaceuticals

$178.88 /

-1.08 (-0.60%)

, TNDM

TNDM

/

+

, BAYRY

Bayer

$17.19 /

+0.16 (+0.94%)

, ANIK

Anika Therapeutics

$44.12 /

+0.11 (+0.25%)

, CVAC

CureVac

$114.37 /

-0.875 (-0.76%)

, BSX

Boston Scientific

$42.81 /

+0.705 (+1.67%)

, APLT

Applied Therapeutics

$17.51 /

+0.26 (+1.51%)

, ARVN

Arvinas

$65.93 /

-0.54 (-0.81%)

, PACB

Pacific Biosciences

$25.78 /

+0.2 (+0.78%)

, ABBV

AbbVie

$115.91 /

-0.2 (-0.17%)

, ZYXI

Zynex

$14.72 /

-0.08 (-0.54%)

, BAX

Baxter

$82.75 /

-0.31 (-0.37%)

, KOD

Kodiak Sciences

$81.22 /

+0.81 (+1.01%)

, ARWR

Arrowhead

$74.77 /

+0.64 (+0.86%)

, CUTR

Cutera

$38.15 /

-0.17 (-0.44%)

, TVTY

Tivity Health

$25.85 /

+0.63 (+2.50%)

, PTCT

PTC Therapeutics

$39.14 /

-0.34 (-0.86%)

, CTLT

Catalent

$102.55 /

+0.76 (+0.75%)

, RHHBY

Roche

$43.16 /

-0.09 (-0.21%)

, CLPT

ClearPoint Neuro

$18.37 /

-0.3 (-1.61%)

, BNTX

BioNTech

$194.87 /

-0.68 (-0.35%)

, ALGN

Align Technology

$604.00 /

+12.52 (+2.12%)

, DBTX

Decibel Therapeutics

$8.06 /

-0.175 (-2.13%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference 2021 to be held on May 24-26.Webcast Link

ShowHide Related Items >><<
ZYXI Zynex
$14.72 /

-0.08 (-0.54%)

TVTY Tivity Health
$25.85 /

+0.63 (+2.50%)

TNDM TNDM
/

+

TERN Terns Pharmaceuticals
$15.80 /

-0.11 (-0.69%)

TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

SIOX Sio Gene Therapies
$2.22 /

+0.015 (+0.68%)

RHHBY Roche
$43.16 /

-0.09 (-0.21%)

PTCT PTC Therapeutics
$39.14 /

-0.34 (-0.86%)

PACB Pacific Biosciences
$25.78 /

+0.2 (+0.78%)

NVS Novartis
$88.00 /

-0.065 (-0.07%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$164.12 /

+2.565 (+1.59%)

KOD Kodiak Sciences
$81.22 /

+0.81 (+1.01%)

JAZZ Jazz Pharmaceuticals
$178.88 /

-1.08 (-0.60%)

ICLR Icon
$232.11 /

+1.2 (+0.52%)

DBTX Decibel Therapeutics
$8.06 /

-0.175 (-2.13%)

CVAC CureVac
$114.37 /

-0.875 (-0.76%)

CUTR Cutera
$38.15 /

-0.17 (-0.44%)

CTLT Catalent
$102.55 /

+0.76 (+0.75%)

CLPT ClearPoint Neuro
$18.37 /

-0.3 (-1.61%)

BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

BRKR Bruker
$69.74 /

+0.64 (+0.93%)

BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

BMRN BioMarin
$77.49 /

-0.63 (-0.81%)

BAYRY Bayer
$17.19 /

+0.16 (+0.94%)

BAX Baxter
$82.75 /

-0.31 (-0.37%)

ARWR Arrowhead
$74.77 /

+0.64 (+0.86%)

ARVN Arvinas
$65.93 /

-0.54 (-0.81%)

APLT Applied Therapeutics
$17.51 /

+0.26 (+1.51%)

AMWL Amwell
$11.54 /

-0.16 (-1.37%)

ALGN Align Technology
$604.00 /

+12.52 (+2.12%)

ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
MRNA Moderna
$164.12 /

+2.565 (+1.59%)

05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
05/07/21 Goldman Sachs
Moderna price target raised to $228 from $206 at Goldman Sachs
05/06/21 Piper Sandler
Moderna price target lowered to $231 from $234 at Piper Sandler
TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

04/12/21 Piper Sandler
Reviews of Tela Bio's OviTex from two KOLs were positive, says Piper Sandler
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
03/25/21 Canaccord
Tela Bio pieces in place for accelerating growth, says Canaccord
01/14/21 Piper Sandler
Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss
ICLR Icon
$232.11 /

+1.2 (+0.52%)

05/10/21 Truist
PRA Health downgraded to Hold from Buy at Truist
05/03/21 Mizuho
Icon price target raised to $242 from $217 at Mizuho
04/29/21 Credit Suisse
Icon price target raised to $245 from $240 at Credit Suisse
04/20/21 Baird
PRA Health downgraded to Neutral from Outperform at Baird
AMWL Amwell
$11.54 /

-0.16 (-1.37%)

05/17/21 Guggenheim
Amwell upgraded to Buy from Neutral at Guggenheim
05/13/21 Piper Sandler
Amwell price target lowered to $20 from $30 at Piper Sandler
05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
BRKR Bruker
$69.74 /

+0.64 (+0.93%)

05/06/21 BTIG
Bruker price target raised to $80 from $73 at BTIG
05/06/21 SVB Leerink
Bruker price target raised to $80 from $70 at SVB Leerink
02/17/21 Stifel
Bruker price target raised to $65 from $48 at Stifel
02/17/21 Citi
Bruker price target raised to $65 from $57 at Citi
SIOX Sio Gene Therapies
$2.22 /

+0.015 (+0.68%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
BMRN BioMarin
$77.49 /

-0.63 (-0.81%)

04/30/21 Wedbush
BioMarin's Q1 revenue was better than expected, says Wedbush
04/26/21 Credit Suisse
BioMarin assumed with an Outperform at Credit Suisse
03/04/21 Guggenheim
BioMarin assumed at Buy from Neutral at Guggenheim
03/01/21 Evercore ISI
BioMarin upgraded to Outperform from In Line at Evercore ISI
NVS Novartis
$88.00 /

-0.065 (-0.07%)

05/11/21 Morgan Stanley
Novartis price target lowered to CHF 99 from CHF 102 at Morgan Stanley
04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
TERN Terns Pharmaceuticals
$15.80 /

-0.11 (-0.69%)

03/02/21 Cowen
Terns initiated with Outperform on NASH potential at Cowen
03/02/21 JPMorgan
Terns Pharmaceuticals initiated with an Overweight at JPMorgan
03/02/21 Cowen
Terns Pharmaceuticals initiated with an Outperform at Cowen
03/02/21 Goldman Sachs
Terns Pharmaceuticals initiated with a Buy at Goldman Sachs
EAR Eargo
$33.22 /

+1.17 (+3.65%)

05/13/21 Wells Fargo
Eargo price target lowered to $52 from $68 at Wells Fargo
05/12/21 JPMorgan
JPMorgan sees four 'compelling' MedTech opportunities after selloff
01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
JAZZ Jazz Pharmaceuticals
$178.88 /

-1.08 (-0.60%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
TNDM TNDM
/

+

05/24/21 Barclays
Tandem Diabetes initiated with an Underweight at Barclays
05/06/21 SVB Leerink
Tandem Diabetes price target raised to $102 from $95 at SVB Leerink
05/06/21 Oppenheimer
Tandem Diabetes price target raised to $135 from $130 at Oppenheimer
05/06/21 Piper Sandler
Tandem Diabetes remains a 'name to buy' after Q1 beat, says Piper Sandler
BAYRY Bayer
$17.19 /

+0.16 (+0.94%)

05/19/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
05/19/21 JPMorgan
JPMorgan upgrades Bayer to Overweight with earnings at 'turning point'
05/18/21 JPMorgan
Bayer upgraded to Overweight from Neutral at JPMorgan
05/14/21 Berenberg
Bayer price target raised to EUR 74 from EUR 68 at Berenberg
ANIK Anika Therapeutics
$44.12 /

+0.11 (+0.25%)

12/16/20 Barrington
Anika Therapeutics upgraded to Outperform with $43 target at Barrington
12/16/20 Barrington
Anika Therapeutics upgraded to Outperform from Market Perform at Barrington
CVAC CureVac
$114.37 /

-0.875 (-0.76%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

05/24/21 Barclays
Boston Scientific initiated with an Overweight at Barclays
05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
04/29/21 Truist
Boston Scientific price target raised to $50 from $42 at Truist
04/29/21 Canaccord
Boston Scientific price target raised to $49 from $44 at Canaccord
APLT Applied Therapeutics
$17.51 /

+0.26 (+1.51%)

11/17/20 Barclays
Applied Therapeutics price target lowered to $44 from $64 at Barclays
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
ARVN Arvinas
$65.93 /

-0.54 (-0.81%)

05/20/21 UBS
Arvinas initiated with a Buy at UBS
04/21/21 Truist
Truist starts Arvinas with a Buy on PROTACs potential
04/21/21 Truist
Arvinas initiated with a Buy at Truist
03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
PACB Pacific Biosciences
$25.78 /

+0.2 (+0.78%)

03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

05/19/21 Piper Sandler
Piper 'incrementally bullish' on Biohaven, AbbVie migraine drugs
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
ZYXI Zynex
$14.72 /

-0.08 (-0.54%)

04/29/21 Piper Sandler
Zynex price target lowered to $15 from $19 at Piper Sandler
03/09/21 Northland
Zynex upgraded to Outperform from Market Perform at Northland
02/26/21 B. Riley
B. Riley downgrades Zynex to Neutral on 'deteriorating profitability'
02/26/21 B. Riley
Zynex downgraded to Neutral from Buy at B. Riley Securities
BAX Baxter
$82.75 /

-0.31 (-0.37%)

05/24/21 Barclays
Baxter initiated with an Equal Weight at Barclays
04/30/21 Citi
Baxter price target raised to $98 from $94 at Citi
04/29/21 Piper Sandler
Baxter price target raised to $85 from $80 at Piper Sandler
03/26/21 JPMorgan
Baxter a 'stock to own' into earnings and beyond, says JPMorgan
KOD Kodiak Sciences
$81.22 /

+0.81 (+1.01%)

05/11/21 Roth Capital
Roth Capital upgrades Kodiak Sciences to Buy on recent selloff
05/11/21 Roth Capital
Kodiak Sciences upgraded to Buy from Neutral at Roth Capital
05/11/21 BMO Capital
Kodiak Sciences price target lowered to $104 from $138 at BMO Capital
05/11/21 Barclays
Kodiak Sciences price target lowered to $86 from $90 at Barclays
ARWR Arrowhead
$74.77 /

+0.64 (+0.86%)

02/08/21 B. Riley
Arrowhead price target raised to $106 from $98 at B. Riley Securities
02/08/21 Citi
Arrowhead price target raised to $110 from $90 at Citi
02/05/21 Chardan
Arrowhead price target raised to $97 from $81 at Chardan
02/05/21 H.C. Wainwright
Arrowhead price target raised to $95 from $90 at H.C. Wainwright
CUTR Cutera
$38.15 /

-0.17 (-0.44%)

03/05/21 Piper Sandler
Cutera price target raised to $42 from $38 at Piper Sandler
02/18/21 Piper Sandler
Cutera price target raised to $38 from $28 at Piper Sandler
11/05/20 Piper Sandler
Cutera price target raised to $28 from $22 at Piper Sandler
09/14/20 Stephens
Cutera price target raised to $24 from $18 at Stephens
TVTY Tivity Health
$25.85 /

+0.63 (+2.50%)

02/25/21 Barrington
Tivity Health price target raised to $32 from $28 at Barrington
02/25/21 Piper Sandler
Tivity Health price target raised to $27 from $16 at Piper Sandler
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform with $19 target at Credit Suisse
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform from Neutral at Credit Suisse
PTCT PTC Therapeutics
$39.14 /

-0.34 (-0.86%)

05/17/21 Truist
PTC Therapeutics price target lowered to $65 from $75 at Truist
04/26/21 Credit Suisse
PTC Therapeutics assumed with a Neutral at Credit Suisse
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
CTLT Catalent
$102.55 /

+0.76 (+0.75%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
RHHBY Roche
$43.16 /

-0.09 (-0.21%)

05/05/21 BTIG
Mereo BioPharma initiated with a Buy at BTIG
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
CLPT ClearPoint Neuro
$18.37 /

-0.3 (-1.61%)

03/18/21 Lake Street
Lake Street starts ClearPoint Neuro at Buy, sees 'billion-dollar' cap potential
03/18/21 Lake Street
ClearPoint Neuro initiated with a Buy at Lake Street
02/22/21 B. Riley
ClearPoint Neuro price target raised to $38 from $23 at B. Riley Securities
01/22/21 B. Riley
ClearPoint Neuro price target raised to $23 from $18 at B. Riley Securities
BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
05/11/21
Fly Intel: Top five analyst downgrades
ALGN Align Technology
$604.00 /

+12.52 (+2.12%)

04/29/21 SVB Leerink
Align Technology price target raised to $770 from $690 at SVB Leerink
04/29/21 Credit Suisse
Align Technology price target raised to $715 from $693 at Credit Suisse
04/29/21 Stifel
Align Technology price target raised to $750 from $650 at Stifel
04/29/21 Baird
Align Technology price target raised to $745 from $655 at Baird
DBTX Decibel Therapeutics
$8.06 /

-0.175 (-2.13%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
ZYXI Zynex
$14.72 /

-0.08 (-0.54%)

TVTY Tivity Health
$25.85 /

+0.63 (+2.50%)

TNDM TNDM
/

+

TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

SIOX Sio Gene Therapies
$2.22 /

+0.015 (+0.68%)

RHHBY Roche
$43.16 /

-0.09 (-0.21%)

PTCT PTC Therapeutics
$39.14 /

-0.34 (-0.86%)

PACB Pacific Biosciences
$25.78 /

+0.2 (+0.78%)

NVS Novartis
$88.00 /

-0.065 (-0.07%)

MRNA Moderna
$164.12 /

+2.565 (+1.59%)

KOD Kodiak Sciences
$81.22 /

+0.81 (+1.01%)

JAZZ Jazz Pharmaceuticals
$178.88 /

-1.08 (-0.60%)

ICLR Icon
$232.11 /

+1.2 (+0.52%)

EAR Eargo
$33.22 /

+1.17 (+3.65%)

CUTR Cutera
$38.15 /

-0.17 (-0.44%)

CTLT Catalent
$102.55 /

+0.76 (+0.75%)

BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

BRKR Bruker
$69.74 /

+0.64 (+0.93%)

BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

BMRN BioMarin
$77.49 /

-0.63 (-0.81%)

BAYRY Bayer
$17.19 /

+0.16 (+0.94%)

BAX Baxter
$82.75 /

-0.31 (-0.37%)

ARWR Arrowhead
$74.77 /

+0.64 (+0.86%)

ARVN Arvinas
$65.93 /

-0.54 (-0.81%)

APLT Applied Therapeutics
$17.51 /

+0.26 (+1.51%)

AMWL Amwell
$11.54 /

-0.16 (-1.37%)

ALGN Align Technology
$604.00 /

+12.52 (+2.12%)

ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

  • 19
    Feb
  • 12
    Feb
  • 12
    Feb
  • 05
    Feb
  • 28
    Jan
  • 15
    Jan
  • 16
    Dec
  • 11
    Dec
  • 23
    Nov
  • 18
    Nov
  • 11
    Nov
  • 21
    Oct
  • 16
    Oct
  • 17
    Sep
  • 12
    Aug
  • 14
    Aug
  • 23
    Jul
  • 15
    Jul
  • 26
    Jun
  • 11
    Jun
RHHBY Roche
$43.16 /

-0.09 (-0.21%)

PACB Pacific Biosciences
$25.78 /

+0.2 (+0.78%)

NVS Novartis
$88.00 /

-0.065 (-0.07%)

MRNA Moderna
$164.12 /

+2.565 (+1.59%)

JAZZ Jazz Pharmaceuticals
$178.88 /

-1.08 (-0.60%)

ICLR Icon
$232.11 /

+1.2 (+0.52%)

CVAC CureVac
$114.37 /

-0.875 (-0.76%)

CTLT Catalent
$102.55 /

+0.76 (+0.75%)

BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

BMRN BioMarin
$77.49 /

-0.63 (-0.81%)

BAYRY Bayer
$17.19 /

+0.16 (+0.94%)

BAX Baxter
$82.75 /

-0.31 (-0.37%)

ARWR Arrowhead
$74.77 /

+0.64 (+0.86%)

ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

TERN Terns Pharmaceuticals
$15.80 /

-0.11 (-0.69%)

SIOX Sio Gene Therapies
$2.22 /

+0.015 (+0.68%)

RHHBY Roche
$43.16 /

-0.09 (-0.21%)

PTCT PTC Therapeutics
$39.14 /

-0.34 (-0.86%)

NVS Novartis
$88.00 /

-0.065 (-0.07%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$164.12 /

+2.565 (+1.59%)

JAZZ Jazz Pharmaceuticals
$178.88 /

-1.08 (-0.60%)

ICLR Icon
$232.11 /

+1.2 (+0.52%)

DBTX Decibel Therapeutics
$8.06 /

-0.175 (-2.13%)

CVAC CureVac
$114.37 /

-0.875 (-0.76%)

CTLT Catalent
$102.55 /

+0.76 (+0.75%)

CLPT ClearPoint Neuro
$18.37 /

-0.3 (-1.61%)

BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

BRKR Bruker
$69.74 /

+0.64 (+0.93%)

BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

BMRN BioMarin
$77.49 /

-0.63 (-0.81%)

BAYRY Bayer
$17.19 /

+0.16 (+0.94%)

BAX Baxter
$82.75 /

-0.31 (-0.37%)

ARWR Arrowhead
$74.77 /

+0.64 (+0.86%)

ARVN Arvinas
$65.93 /

-0.54 (-0.81%)

APLT Applied Therapeutics
$17.51 /

+0.26 (+1.51%)

AMWL Amwell
$11.54 /

-0.16 (-1.37%)

ALGN Align Technology
$604.00 /

+12.52 (+2.12%)

ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

ZYXI Zynex
$14.72 /

-0.08 (-0.54%)

SIOX Sio Gene Therapies
$2.22 /

+0.015 (+0.68%)

PACB Pacific Biosciences
$25.78 /

+0.2 (+0.78%)

MRNA Moderna
$164.12 /

+2.565 (+1.59%)

EAR Eargo
$33.22 /

+1.17 (+3.65%)

CVAC CureVac
$114.37 /

-0.875 (-0.76%)

CLPT ClearPoint Neuro
$18.37 /

-0.3 (-1.61%)

BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

AMWL Amwell
$11.54 /

-0.16 (-1.37%)

ALGN Align Technology
$604.00 /

+12.52 (+2.12%)

ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

Conference/Events
UBS to hold a virtual conference » 10:02
05/24/21
05/24
10:02
05/24/21
10:02
NBTX

Nanobiotix

$16.16 /

+ (+0.00%)

, MRNA

Moderna

$164.80 /

+3.245 (+2.01%)

, TELA

Tela Bio

$13.25 /

-0.05 (-0.38%)

, ICLR

Icon

$232.40 /

+1.49 (+0.65%)

, AMWL

Amwell

$11.69 /

-0.01 (-0.09%)

, BRKR

Bruker

$69.47 /

+0.37 (+0.54%)

, SIOX

Sio Gene Therapies

$2.19 /

-0.015 (-0.68%)

, BMRN

BioMarin

$78.16 /

+0.04 (+0.05%)

, NVS

Novartis

$88.27 /

+0.205 (+0.23%)

, TERN

Terns Pharmaceuticals

$15.89 /

-0.02 (-0.13%)

, EAR

Eargo

$32.32 /

+0.27 (+0.84%)

, JAZZ

Jazz Pharmaceuticals

$180.90 /

+0.94 (+0.52%)

, TNDM

TNDM

/

+

, BAYRY

Bayer

$17.03 /

+0.065 (+0.38%)

, ANIK

Anika Therapeutics

$44.01 /

+ (+0.00%)

, CVAC

CureVac

$117.23 /

+1.99 (+1.73%)

, BSX

Boston Scientific

$42.27 /

+0.17 (+0.40%)

, APLT

Applied Therapeutics

$17.22 /

-0.03 (-0.17%)

, ARVN

Arvinas

$66.28 /

-0.19 (-0.29%)

, PACB

Pacific Biosciences

$26.66 /

+1.08 (+4.22%)

, ABBV

AbbVie

$115.99 /

-0.12 (-0.10%)

, ZYXI

Zynex

$15.03 /

+0.23 (+1.55%)

, BAX

Baxter

$82.93 /

-0.13 (-0.16%)

, KOD

Kodiak Sciences

$80.94 /

+0.53 (+0.66%)

, ARWR

Arrowhead

$75.00 /

+0.87 (+1.17%)

, CUTR

Cutera

$38.64 /

+0.32 (+0.84%)

, TVTY

Tivity Health

$25.26 /

+0.04 (+0.16%)

, PTCT

PTC Therapeutics

$39.80 /

+0.32 (+0.81%)

, CTLT

Catalent

$101.85 /

+0.06 (+0.06%)

, RHHBY

Roche

$43.25 /

+0.32 (+0.75%)

, CLPT

ClearPoint Neuro

$18.55 /

-0.12 (-0.64%)

, BNTX

BioNTech

$199.00 /

+3.45 (+1.76%)

, ALGN

Align Technology

$601.02 /

+9.54 (+1.61%)

, DBTX

Decibel Therapeutics

$8.08 /

-0.15 (-1.82%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference 2021 to be held on May 24-26.Webcast Link

ShowHide Related Items >><<
ZYXI Zynex
$15.03 /

+0.23 (+1.55%)

TVTY Tivity Health
$25.26 /

+0.04 (+0.16%)

TNDM TNDM
/

+

TERN Terns Pharmaceuticals
$15.89 /

-0.02 (-0.13%)

TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

SIOX Sio Gene Therapies
$2.19 /

-0.015 (-0.68%)

RHHBY Roche
$43.25 /

+0.32 (+0.75%)

PTCT PTC Therapeutics
$39.80 /

+0.32 (+0.81%)

PACB Pacific Biosciences
$26.66 /

+1.08 (+4.22%)

NVS Novartis
$88.27 /

+0.205 (+0.23%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$164.80 /

+3.245 (+2.01%)

KOD Kodiak Sciences
$80.94 /

+0.53 (+0.66%)

JAZZ Jazz Pharmaceuticals
$180.90 /

+0.94 (+0.52%)

ICLR Icon
$232.40 /

+1.49 (+0.65%)

DBTX Decibel Therapeutics
$8.08 /

-0.15 (-1.82%)

CVAC CureVac
$117.23 /

+1.99 (+1.73%)

CUTR Cutera
$38.64 /

+0.32 (+0.84%)

CTLT Catalent
$101.85 /

+0.06 (+0.06%)

CLPT ClearPoint Neuro
$18.55 /

-0.12 (-0.64%)

BSX Boston Scientific
$42.27 /

+0.17 (+0.40%)

BRKR Bruker
$69.47 /

+0.37 (+0.54%)

BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

BMRN BioMarin
$78.16 /

+0.04 (+0.05%)

BAYRY Bayer
$17.03 /

+0.065 (+0.38%)

BAX Baxter
$82.93 /

-0.13 (-0.16%)

ARWR Arrowhead
$75.00 /

+0.87 (+1.17%)

ARVN Arvinas
$66.28 /

-0.19 (-0.29%)

APLT Applied Therapeutics
$17.22 /

-0.03 (-0.17%)

AMWL Amwell
$11.69 /

-0.01 (-0.09%)

ALGN Align Technology
$601.02 /

+9.54 (+1.61%)

ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
MRNA Moderna
$164.80 /

+3.245 (+2.01%)

05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
05/07/21 Goldman Sachs
Moderna price target raised to $228 from $206 at Goldman Sachs
05/06/21 Piper Sandler
Moderna price target lowered to $231 from $234 at Piper Sandler
TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

04/12/21 Piper Sandler
Reviews of Tela Bio's OviTex from two KOLs were positive, says Piper Sandler
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
03/25/21 Canaccord
Tela Bio pieces in place for accelerating growth, says Canaccord
01/14/21 Piper Sandler
Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss
ICLR Icon
$232.40 /

+1.49 (+0.65%)

05/10/21 Truist
PRA Health downgraded to Hold from Buy at Truist
05/03/21 Mizuho
Icon price target raised to $242 from $217 at Mizuho
04/29/21 Credit Suisse
Icon price target raised to $245 from $240 at Credit Suisse
04/20/21 Baird
PRA Health downgraded to Neutral from Outperform at Baird
AMWL Amwell
$11.69 /

-0.01 (-0.09%)

05/17/21 Guggenheim
Amwell upgraded to Buy from Neutral at Guggenheim
05/13/21 Piper Sandler
Amwell price target lowered to $20 from $30 at Piper Sandler
05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
BRKR Bruker
$69.47 /

+0.37 (+0.54%)

05/06/21 BTIG
Bruker price target raised to $80 from $73 at BTIG
05/06/21 SVB Leerink
Bruker price target raised to $80 from $70 at SVB Leerink
02/17/21 Stifel
Bruker price target raised to $65 from $48 at Stifel
02/17/21 Citi
Bruker price target raised to $65 from $57 at Citi
SIOX Sio Gene Therapies
$2.19 /

-0.015 (-0.68%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
BMRN BioMarin
$78.16 /

+0.04 (+0.05%)

04/30/21 Wedbush
BioMarin's Q1 revenue was better than expected, says Wedbush
04/26/21 Credit Suisse
BioMarin assumed with an Outperform at Credit Suisse
03/04/21 Guggenheim
BioMarin assumed at Buy from Neutral at Guggenheim
03/01/21 Evercore ISI
BioMarin upgraded to Outperform from In Line at Evercore ISI
NVS Novartis
$88.27 /

+0.205 (+0.23%)

05/11/21 Morgan Stanley
Novartis price target lowered to CHF 99 from CHF 102 at Morgan Stanley
04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
TERN Terns Pharmaceuticals
$15.89 /

-0.02 (-0.13%)

03/02/21 Cowen
Terns initiated with Outperform on NASH potential at Cowen
03/02/21 JPMorgan
Terns Pharmaceuticals initiated with an Overweight at JPMorgan
03/02/21 Cowen
Terns Pharmaceuticals initiated with an Outperform at Cowen
03/02/21 Goldman Sachs
Terns Pharmaceuticals initiated with a Buy at Goldman Sachs
EAR Eargo
$32.32 /

+0.27 (+0.84%)

05/13/21 Wells Fargo
Eargo price target lowered to $52 from $68 at Wells Fargo
05/12/21 JPMorgan
JPMorgan sees four 'compelling' MedTech opportunities after selloff
01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
JAZZ Jazz Pharmaceuticals
$180.90 /

+0.94 (+0.52%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
TNDM TNDM
/

+

05/06/21 SVB Leerink
Tandem Diabetes price target raised to $102 from $95 at SVB Leerink
05/06/21 Oppenheimer
Tandem Diabetes price target raised to $135 from $130 at Oppenheimer
05/06/21 Piper Sandler
Tandem Diabetes remains a 'name to buy' after Q1 beat, says Piper Sandler
03/12/21 Piper Sandler
Tandem Diabetes competition concerns overblown, says Piper Sandler
BAYRY Bayer
$17.03 /

+0.065 (+0.38%)

05/19/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
05/19/21 JPMorgan
JPMorgan upgrades Bayer to Overweight with earnings at 'turning point'
05/18/21 JPMorgan
Bayer upgraded to Overweight from Neutral at JPMorgan
05/14/21 Berenberg
Bayer price target raised to EUR 74 from EUR 68 at Berenberg
ANIK Anika Therapeutics
$44.01 /

+ (+0.00%)

12/16/20 Barrington
Anika Therapeutics upgraded to Outperform with $43 target at Barrington
12/16/20 Barrington
Anika Therapeutics upgraded to Outperform from Market Perform at Barrington
CVAC CureVac
$117.23 /

+1.99 (+1.73%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
BSX Boston Scientific
$42.27 /

+0.17 (+0.40%)

05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
04/29/21 Truist
Boston Scientific price target raised to $50 from $42 at Truist
04/29/21 Canaccord
Boston Scientific price target raised to $49 from $44 at Canaccord
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
APLT Applied Therapeutics
$17.22 /

-0.03 (-0.17%)

11/17/20 Barclays
Applied Therapeutics price target lowered to $44 from $64 at Barclays
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
ARVN Arvinas
$66.28 /

-0.19 (-0.29%)

05/20/21 UBS
Arvinas initiated with a Buy at UBS
04/21/21 Truist
Truist starts Arvinas with a Buy on PROTACs potential
04/21/21 Truist
Arvinas initiated with a Buy at Truist
03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
PACB Pacific Biosciences
$26.66 /

+1.08 (+4.22%)

03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

05/19/21 Piper Sandler
Piper 'incrementally bullish' on Biohaven, AbbVie migraine drugs
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
ZYXI Zynex
$15.03 /

+0.23 (+1.55%)

04/29/21 Piper Sandler
Zynex price target lowered to $15 from $19 at Piper Sandler
03/09/21 Northland
Zynex upgraded to Outperform from Market Perform at Northland
02/26/21 B. Riley
B. Riley downgrades Zynex to Neutral on 'deteriorating profitability'
02/26/21 B. Riley
Zynex downgraded to Neutral from Buy at B. Riley Securities
BAX Baxter
$82.93 /

-0.13 (-0.16%)

04/30/21 Citi
Baxter price target raised to $98 from $94 at Citi
04/29/21 Piper Sandler
Baxter price target raised to $85 from $80 at Piper Sandler
03/26/21 JPMorgan
Baxter a 'stock to own' into earnings and beyond, says JPMorgan
03/22/21 Benchmark
Omnicell price target raised to $155 from $140 at Benchmark
KOD Kodiak Sciences
$80.94 /

+0.53 (+0.66%)

05/11/21 Roth Capital
Roth Capital upgrades Kodiak Sciences to Buy on recent selloff
05/11/21 Roth Capital
Kodiak Sciences upgraded to Buy from Neutral at Roth Capital
05/11/21 BMO Capital
Kodiak Sciences price target lowered to $104 from $138 at BMO Capital
05/11/21 Barclays
Kodiak Sciences price target lowered to $86 from $90 at Barclays
ARWR Arrowhead
$75.00 /

+0.87 (+1.17%)

02/08/21 B. Riley
Arrowhead price target raised to $106 from $98 at B. Riley Securities
02/08/21 Citi
Arrowhead price target raised to $110 from $90 at Citi
02/05/21 Chardan
Arrowhead price target raised to $97 from $81 at Chardan
02/05/21 H.C. Wainwright
Arrowhead price target raised to $95 from $90 at H.C. Wainwright
CUTR Cutera
$38.64 /

+0.32 (+0.84%)

03/05/21 Piper Sandler
Cutera price target raised to $42 from $38 at Piper Sandler
02/18/21 Piper Sandler
Cutera price target raised to $38 from $28 at Piper Sandler
11/05/20 Piper Sandler
Cutera price target raised to $28 from $22 at Piper Sandler
09/14/20 Stephens
Cutera price target raised to $24 from $18 at Stephens
TVTY Tivity Health
$25.26 /

+0.04 (+0.16%)

02/25/21 Barrington
Tivity Health price target raised to $32 from $28 at Barrington
02/25/21 Piper Sandler
Tivity Health price target raised to $27 from $16 at Piper Sandler
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform with $19 target at Credit Suisse
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform from Neutral at Credit Suisse
PTCT PTC Therapeutics
$39.80 /

+0.32 (+0.81%)

05/17/21 Truist
PTC Therapeutics price target lowered to $65 from $75 at Truist
04/26/21 Credit Suisse
PTC Therapeutics assumed with a Neutral at Credit Suisse
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
CTLT Catalent
$101.85 /

+0.06 (+0.06%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
RHHBY Roche
$43.25 /

+0.32 (+0.75%)

05/05/21 BTIG
Mereo BioPharma initiated with a Buy at BTIG
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
CLPT ClearPoint Neuro
$18.55 /

-0.12 (-0.64%)

03/18/21 Lake Street
Lake Street starts ClearPoint Neuro at Buy, sees 'billion-dollar' cap potential
03/18/21 Lake Street
ClearPoint Neuro initiated with a Buy at Lake Street
02/22/21 B. Riley
ClearPoint Neuro price target raised to $38 from $23 at B. Riley Securities
01/22/21 B. Riley
ClearPoint Neuro price target raised to $23 from $18 at B. Riley Securities
BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
05/11/21
Fly Intel: Top five analyst downgrades
ALGN Align Technology
$601.02 /

+9.54 (+1.61%)

04/29/21 SVB Leerink
Align Technology price target raised to $770 from $690 at SVB Leerink
04/29/21 Credit Suisse
Align Technology price target raised to $715 from $693 at Credit Suisse
04/29/21 Stifel
Align Technology price target raised to $750 from $650 at Stifel
04/29/21 Baird
Align Technology price target raised to $745 from $655 at Baird
DBTX Decibel Therapeutics
$8.08 /

-0.15 (-1.82%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
ZYXI Zynex
$15.03 /

+0.23 (+1.55%)

TVTY Tivity Health
$25.26 /

+0.04 (+0.16%)

TNDM TNDM
/

+

TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

SIOX Sio Gene Therapies
$2.19 /

-0.015 (-0.68%)

RHHBY Roche
$43.25 /

+0.32 (+0.75%)

PTCT PTC Therapeutics
$39.80 /

+0.32 (+0.81%)

PACB Pacific Biosciences
$26.66 /

+1.08 (+4.22%)

NVS Novartis
$88.27 /

+0.205 (+0.23%)

MRNA Moderna
$164.80 /

+3.245 (+2.01%)

KOD Kodiak Sciences
$80.94 /

+0.53 (+0.66%)

JAZZ Jazz Pharmaceuticals
$180.90 /

+0.94 (+0.52%)

ICLR Icon
$232.40 /

+1.49 (+0.65%)

EAR Eargo
$32.32 /

+0.27 (+0.84%)

CUTR Cutera
$38.64 /

+0.32 (+0.84%)

CTLT Catalent
$101.85 /

+0.06 (+0.06%)

BSX Boston Scientific
$42.27 /

+0.17 (+0.40%)

BRKR Bruker
$69.47 /

+0.37 (+0.54%)

BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

BMRN BioMarin
$78.16 /

+0.04 (+0.05%)

BAYRY Bayer
$17.03 /

+0.065 (+0.38%)

BAX Baxter
$82.93 /

-0.13 (-0.16%)

ARWR Arrowhead
$75.00 /

+0.87 (+1.17%)

ARVN Arvinas
$66.28 /

-0.19 (-0.29%)

APLT Applied Therapeutics
$17.22 /

-0.03 (-0.17%)

AMWL Amwell
$11.69 /

-0.01 (-0.09%)

ALGN Align Technology
$601.02 /

+9.54 (+1.61%)

ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

  • 19
    Feb
  • 12
    Feb
  • 12
    Feb
  • 05
    Feb
  • 28
    Jan
  • 15
    Jan
  • 16
    Dec
  • 11
    Dec
  • 23
    Nov
  • 18
    Nov
  • 11
    Nov
  • 21
    Oct
  • 16
    Oct
  • 17
    Sep
  • 12
    Aug
  • 14
    Aug
  • 23
    Jul
  • 15
    Jul
  • 26
    Jun
  • 11
    Jun
RHHBY Roche
$43.25 /

+0.32 (+0.75%)

PACB Pacific Biosciences
$26.66 /

+1.08 (+4.22%)

NVS Novartis
$88.27 /

+0.205 (+0.23%)

MRNA Moderna
$164.80 /

+3.245 (+2.01%)

JAZZ Jazz Pharmaceuticals
$180.90 /

+0.94 (+0.52%)

ICLR Icon
$232.40 /

+1.49 (+0.65%)

CVAC CureVac
$117.23 /

+1.99 (+1.73%)

CTLT Catalent
$101.85 /

+0.06 (+0.06%)

BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

BMRN BioMarin
$78.16 /

+0.04 (+0.05%)

BAYRY Bayer
$17.03 /

+0.065 (+0.38%)

BAX Baxter
$82.93 /

-0.13 (-0.16%)

ARWR Arrowhead
$75.00 /

+0.87 (+1.17%)

ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

TERN Terns Pharmaceuticals
$15.89 /

-0.02 (-0.13%)

SIOX Sio Gene Therapies
$2.19 /

-0.015 (-0.68%)

RHHBY Roche
$43.25 /

+0.32 (+0.75%)

PTCT PTC Therapeutics
$39.80 /

+0.32 (+0.81%)

NVS Novartis
$88.27 /

+0.205 (+0.23%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$164.80 /

+3.245 (+2.01%)

JAZZ Jazz Pharmaceuticals
$180.90 /

+0.94 (+0.52%)

ICLR Icon
$232.40 /

+1.49 (+0.65%)

DBTX Decibel Therapeutics
$8.08 /

-0.15 (-1.82%)

CVAC CureVac
$117.23 /

+1.99 (+1.73%)

CTLT Catalent
$101.85 /

+0.06 (+0.06%)

CLPT ClearPoint Neuro
$18.55 /

-0.12 (-0.64%)

BSX Boston Scientific
$42.27 /

+0.17 (+0.40%)

BRKR Bruker
$69.47 /

+0.37 (+0.54%)

BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

BMRN BioMarin
$78.16 /

+0.04 (+0.05%)

BAYRY Bayer
$17.03 /

+0.065 (+0.38%)

BAX Baxter
$82.93 /

-0.13 (-0.16%)

ARWR Arrowhead
$75.00 /

+0.87 (+1.17%)

ARVN Arvinas
$66.28 /

-0.19 (-0.29%)

APLT Applied Therapeutics
$17.22 /

-0.03 (-0.17%)

AMWL Amwell
$11.69 /

-0.01 (-0.09%)

ALGN Align Technology
$601.02 /

+9.54 (+1.61%)

ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

ZYXI Zynex
$15.03 /

+0.23 (+1.55%)

SIOX Sio Gene Therapies
$2.19 /

-0.015 (-0.68%)

PACB Pacific Biosciences
$26.66 /

+1.08 (+4.22%)

MRNA Moderna
$164.80 /

+3.245 (+2.01%)

EAR Eargo
$32.32 /

+0.27 (+0.84%)

CVAC CureVac
$117.23 /

+1.99 (+1.73%)

CLPT ClearPoint Neuro
$18.55 /

-0.12 (-0.64%)

BSX Boston Scientific
$42.27 /

+0.17 (+0.40%)

BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

AMWL Amwell
$11.69 /

-0.01 (-0.09%)

ALGN Align Technology
$601.02 /

+9.54 (+1.61%)

ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

Hot Stocks
Sio Gene Therapies announces data from clinical trial studying AXO-AAV-GM1 » 07:27
05/13/21
05/13
07:27
05/13/21
07:27
SIOX

Sio Gene Therapies

$2.56 /

+0.115 (+4.70%)

Sio Gene Therapies will…

Sio Gene Therapies will present new biomarker data from the Company's study of AXO-AAV-GM1, its adeno-associated viral vector 9-based gene therapy candidate for the treatment of GM1 gangliosidosis, at the 24th Annual Meeting of the American Society of Gene & Cell Therapy, or ASGCT, May 13, 2021. Dr. Cynthia Tifft, Deputy Clinical Director of the National Human Genome Research Institute and Principal Investigator in the study, will review patient-level data on safety and efficacy at six-months follow-up from the low-dose cohort of the company's ongoing Phase 1/2 clinical study, with a focus on new six-month biomarker data from cerebrospinal fluid. Key findings from the new biomarker analysis: 18-49% reductions from baseline in accumulated substrate, GM1 ganglioside, were observed in CSF of 4 out of 5 children in the low-dose cohort at 6 months; 3 out of 5 children demonstrated CSF GM1 ganglioside levels less than 100 ng/mL at the 6-month follow-up visit; one child, whose disease was the most advanced at baseline and who worsened on certain clinical parameters, exhibited an increase in CSF GM1 ganglioside of 19% from baseline at 6 months; literature reported mean levels of normal GM1 ganglioside in CSF range from 29.7- 52.3 ng/ml in healthy children 1 month to 18 years of age; these data represent the first direct evidence in humans that intravenously administered AXO-AAV-GM1 gene therapy exerts a measurable biochemical effect on GM1 ganglioside accumulation within the central nervous system; builds upon previous findings of widespread CNS transfection, disease modification, and improved survival in naturally occurring feline models. These preclinical studies suggest progressive normalization of GM1 ganglioside content in brain regions beginning at 4 months after intravenous gene therapy and continuing until 42 months of age; and additional evidence from a murine model of GM1 gangliosidosis suggests that the blood-brain barrier is more permeable than healthy controls due to local neuroinflammation, supporting the view that intravenous administration of AAV9 may enable widespread CNS distribution in GM1 gangliosidosis. Upcoming milestons for the study include: 12-month data from the low-dose cohort in the second half of 2021; 12-month data from the first two children dosed in the high-dose cohort in Q1 2022; and in the first half of 2022, meeting with the Food and Drug Administration to discuss the registrational pathway for AXO-AAV-GM1. The clinical study is designed to evaluate the safety, tolerability, and potential efficacy of AXO-AAV-GM1 delivered intravenously in children with Type I and Type II GM1 gangliosidosis. Stage 1 is a dose-escalation study in which the low-dose cohort is evaluating 1.5x1013 vg/kg and the high-dose cohort is evaluating a dose of 4.5x1013 vg/kg in early infantile, late infantile, and juvenile children.

ShowHide Related Items >><<
SIOX Sio Gene Therapies
$2.56 /

+0.115 (+4.70%)

SIOX Sio Gene Therapies
$2.56 /

+0.115 (+4.70%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
SIOX Sio Gene Therapies
$2.56 /

+0.115 (+4.70%)

SIOX Sio Gene Therapies
$2.56 /

+0.115 (+4.70%)

SIOX Sio Gene Therapies
$2.56 /

+0.115 (+4.70%)

Over a quarter ago
Initiation
Fly Intel: Top five analyst initiations » 09:56
04/30/21
04/30
09:56
04/30/21
09:56
DKNG

DraftKings

$57.33 /

-0.115 (-0.20%)

, SIOX

Sio Gene Therapies

$2.87 /

+0.17 (+6.30%)

, NRIX

Nurix Therapeutics

$34.84 /

+ (+0.00%)

, CYCC

Cyclacel Pharmaceuticals

$7.35 /

+0.25 (+3.52%)

, CSTL

Castle Biosciences

$67.90 /

-0.19 (-0.28%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. DraftKings (DKNG) initiated with a Buy at Guggenheim. 2. Sio Gene Therapies (SIOX) initiated with a Buy at H.C. Wainwright. 3. Nurix Therapeutics (NRIX) initiated with an Outperform at RBC Capital. 4. Cyclacel Pharmaceuticals (CYCC) initiated with an Outperform at Oppenheimer. 5. Castle Biosciences (CSTL) initiated with a Buy at Lake Street. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
SIOX Sio Gene Therapies
$2.87 /

+0.17 (+6.30%)

NRIX Nurix Therapeutics
$34.84 /

+ (+0.00%)

DKNG DraftKings
$57.33 /

-0.115 (-0.20%)

CYCC Cyclacel Pharmaceuticals
$7.35 /

+0.25 (+3.52%)

CSTL Castle Biosciences
$67.90 /

-0.19 (-0.28%)

DKNG DraftKings
$57.33 /

-0.115 (-0.20%)

04/30/21 Guggenheim
Guggenheim starts DraftKings with Buy on 'significant share' opportunity
04/30/21 Guggenheim
DraftKings initiated with a Buy at Guggenheim
04/26/21 Needham
DraftKings initiated with a Buy at Needham
04/07/21 Truist
Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud'
SIOX Sio Gene Therapies
$2.87 /

+0.17 (+6.30%)

04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
NRIX Nurix Therapeutics
$34.84 /

+ (+0.00%)

04/30/21 RBC Capital
Nurix Therapeutics initiated with an Outperform at RBC Capital
04/30/21 RBC Capital
Nurix Therapeutics initiated with an Outperform at RBC Capital
04/30/21 Piper Sandler
Nurix Therapeutics assumed with an Overweight at Piper Sandler
04/14/21 Berenberg
Nurix Therapeutics initiated with a Buy at Berenberg
CYCC Cyclacel Pharmaceuticals
$7.35 /

+0.25 (+3.52%)

04/30/21 Oppenheimer
Cyclacel Pharmaceuticals initiated with an Outperform at Oppenheimer
04/29/21 Oppenheimer
Cyclacel Pharmaceuticals initiated with an Outperform at Oppenheimer
05/19/20 Brookline
Cyclacel Pharmaceuticals initiated with a Buy at Brookline
CSTL Castle Biosciences
$67.90 /

-0.19 (-0.28%)

04/30/21 Lake Street
Castle Biosciences initiated with a Buy at Lake Street
03/09/21 Baird
Castle Biosciences price target lowered to $82 from $87 at Baird
02/03/21 KeyBanc
Castle Biosciences price target raised to $90 from $70 at KeyBanc
01/26/21 Canaccord
Castle Biosciences price target raised to $84 from $80 at Canaccord
SIOX Sio Gene Therapies
$2.87 /

+0.17 (+6.30%)

NRIX Nurix Therapeutics
$34.84 /

+ (+0.00%)

DKNG DraftKings
$57.33 /

-0.115 (-0.20%)

CYCC Cyclacel Pharmaceuticals
$7.35 /

+0.25 (+3.52%)

CSTL Castle Biosciences
$67.90 /

-0.19 (-0.28%)

  • 12
    Mar
  • 05
    Mar
  • 16
    Dec
  • 07
    Oct
  • 24
    Jul
  • 25
    Jun
  • 19
    Jun
DKNG DraftKings
$57.33 /

-0.115 (-0.20%)

SIOX Sio Gene Therapies
$2.87 /

+0.17 (+6.30%)

DKNG DraftKings
$57.33 /

-0.115 (-0.20%)

CSTL Castle Biosciences
$67.90 /

-0.19 (-0.28%)

SIOX Sio Gene Therapies
$2.87 /

+0.17 (+6.30%)

NRIX Nurix Therapeutics
$34.84 /

+ (+0.00%)

DKNG DraftKings
$57.33 /

-0.115 (-0.20%)

CYCC Cyclacel Pharmaceuticals
$7.35 /

+0.25 (+3.52%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.